Apotea AB (publ)

BATS-CHIXE:APOTES Stock Report

Market Cap: SEK 7.8b

Apotea Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of APOTES?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,896,2132.78%
General Public14,058,80313.5%
Private Companies30,313,13529.1%
Institutions56,802,81554.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 90.21% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
29.1%
Laulima AB
30,313,135SEK 2.3b0%no data
12.5%
Alecta Pensionsförsäkring, ömsesidigt
13,019,465SEK 973.2m0%0.22%
10.3%
Nordea Investment Management, AB
10,712,594SEK 800.8m3.09%0.04%
7.79%
Skandinaviska Enskilda Banken AB (publ)
8,102,350SEK 605.7m0%0.55%
4.97%
Capital Research and Management Company
5,173,165SEK 386.7m0%no data
4.89%
Ernström & Co AB
5,086,553SEK 380.2m0%13.17%
4.82%
Creades AB
5,013,000SEK 374.7m0%4.04%
3.35%
WCM Investment Management, LLC
3,488,275SEK 260.7m0%0.03%
2.34%
Avanza Fonder AB
2,440,057SEK 182.4m0%0.17%
1.86%
BlackRock, Inc.
1,938,075SEK 144.9m0%no data
1.73%
Par Svardson
1,804,881SEK 134.9m4.7%no data
1.06%
C WorldWide Asset Management Fondsmaeglerselskab A/S
1,100,000SEK 82.2m0%0.09%
0.87%
Deka Investment GmbH
908,310SEK 67.9m0%no data
0.58%
American Century Investment Management Inc
600,103SEK 44.9m95.9%no data
0.55%
FMR LLC
568,527SEK 42.5m-28%no data
0.53%
Anders Eriksson
547,776SEK 40.9m0%no data
0.46%
Aperture Investors, LLC
482,447SEK 36.1m0%0.18%
0.44%
Evli Fund Management Company Ltd.
454,972SEK 34.0m0%0.08%
0.41%
Allianz Asset Management GmbH
425,016SEK 31.8m0%no data
0.39%
Polar Capital Holdings Plc
402,589SEK 30.1m-40.5%0.01%
0.39%
Causeway Capital Management LLC
402,069SEK 30.1m0%0.01%
0.34%
Monica Lindstedt
350,230SEK 26.2m94.4%no data
0.22%
Eaton Vance Management
226,567SEK 16.9m0%no data
0.19%
Brock Milton Capital AB (publ)
196,803SEK 14.7m0%0.07%
0.12%
Deutsche Asset & Wealth Management
125,249SEK 9.4m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/13 06:16
End of Day Share Price 2026/04/15 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Apotea AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Niklas EkmanDNB Carnegie